Volker Schellenberger

This inventor holds 68 USPTO granted patents and 53 published patent applications, plus 9 CIPO patents and 29 EPO patents, primarily in Polypeptide Engineering (CPC class C07K). Top assignees: Amunix Operating Inc., Genencor International, Inc., Amunix Pharmaceuticals, Inc. Active years: 1998-2026.

USPTO Granted Patents = 68 (Patent Applications = 53)

% Patents Active = 82.4

CIPO Patents = 9 (Patent Applications = 15)

EPO Patents = 29 (Patent Applications = 36)

Average Co-Inventor Count = 4.1

ph-index = 21

Forward Citations = 1,287(Granted Patents)

Forward Citations (Not Self Cited) = 969(Dec 10, 2025)

Inventors with similar research interests:

Location History:

Burlingame, CA (US) (1998 - 2005)
Palo Alto, CA (US) (2000 - 2024)

Company Filing History:

24 out of 24

Amunix Operating Inc.

patents

19 out of 422

Genencor International, Inc.

patents

11 out of 11

Amunix Pharmaceuticals, Inc

The Procter Gamble Company

patents

6. 2 out of 76

Bioverativ Therapeutics Inc.

Eli Lilly and Company

patents

9. 1 out of 1,890

Life Technologies Corporation

patents

10. 1 out of 834,411

Other

patents

where one patent can have more than one assignee

Years Active: 1998-2026

Loading Chart...

Areas of Expertise:

Polypeptide

Bispecific Compositions

Glucose-Regulating Proteins

Fusion Proteins

Recombinant Polypeptides

Binding Fusion Proteins

Epidermal Growth Factor

Prostate-Specific Antigen

HER-2

Factor VIII

Coagulation Factors

CAB Molecules

68 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12617815 - Barcoded XTEN polypeptides and compositions thereof, and methods for making and using the same (2026-05-05),

2. 12590159 - Compositions targeting epidermal growth factor receptor and methods for making and using the same (2026-03-31),

3. 12428494 - Compositions targeting prostate-specific membrane antigen and methods for making and using the same (2025-09-30),

4. 12215156 - HER-2 targeted bispecific compositions and methods for making and using the same (2025-02-04),

5. 12071456 - Extended recombinant polypeptides and compositions comprising same (2024-08-27),

6. 12060424 - Release segments and binding compositions comprising same (2024-08-13),

7. 11981744 - Chimeric polypeptide assembly and methods of making and using the same (2024-05-14),

8. 11713358 - Chimeric polypeptide assembly and methods of making and using the same (2023-08-01),

9. 10961287 - Extended recombinant polypeptides and compositions comprising same (2021-03-30),

10. 10953073 - XTEN conjugate compositions and methods of making same (2021-03-23),

11. 10870874 - Binding fusion proteins, binding fusion protein-drug conjugates, XTEN-drug conjugates and methods of making and using same (2020-12-22),

12. 10548953 - Factor VIII-XTEN fusions and uses thereof (2020-02-04),

13. 10421798 - Factor VIII compositions and methods of making and using same (2019-09-24),

14. 10195579 - Multi-through hole testing plate for high throughput screening (2019-02-05),

15. 10172953 - XTEN conjugate compositions and methods of making same (2019-01-08),

Title: The Innovative Journey of Volker Schellenberger

Introduction: Volker Schellenberger is a renowned inventor based in Palo Alto, CA, known for his groundbreaking contributions to various fields.

Latest Patents: Volker Schellenberger holds several patents in the areas of biotechnology, medical devices, and renewable energy, showcasing his diverse expertise.

Career Highlights: With a career spanning over two decades, Schellenberger has worked with leading research institutions and companies, developing cutting-edge technologies that have revolutionized their respective industries.

Collaborations: Throughout his career, Volker Schellenberger has collaborated with top scientists, engineers, and innovators, fostering a culture of innovation and excellence in all his projects.

Conclusion: Volker Schellenberger's passion for innovation and his relentless pursuit of excellence continue to inspire the next generation of inventors and entrepreneurs.